- Home
- EBS vs NBB Comparison
EBS vs NBB Comparison
Compare EBS & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- NBB
- Stock Information
- Founded
- EBS 1998
- NBB 2009
- Country
- EBS United States
- NBB United States
- Employees
- EBS N/A
- NBB N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- NBB Finance Companies
- Sector
- EBS Health Care
- NBB Finance
- Exchange
- EBS Nasdaq
- NBB Nasdaq
- Market Cap
- EBS 423.6M
- NBB 470.6M
- IPO Year
- EBS 2006
- NBB N/A
- Fundamental
- Price
- EBS $9.14
- NBB $16.28
- Analyst Decision
- EBS Strong Buy
- NBB
- Analyst Count
- EBS 2
- NBB 0
- Target Price
- EBS $13.50
- NBB N/A
- AVG Volume (30 Days)
- EBS 959.0K
- NBB 73.9K
- Earning Date
- EBS 11-05-2025
- NBB 01-01-0001
- Dividend Yield
- EBS N/A
- NBB 8.64%
- EPS Growth
- EBS N/A
- NBB N/A
- EPS
- EBS 2.53
- NBB N/A
- Revenue
- EBS $851,600,000.00
- NBB N/A
- Revenue This Year
- EBS N/A
- NBB N/A
- Revenue Next Year
- EBS $19.24
- NBB N/A
- P/E Ratio
- EBS $3.62
- NBB N/A
- Revenue Growth
- EBS N/A
- NBB N/A
- 52 Week Low
- EBS $4.02
- NBB $13.67
- 52 Week High
- EBS $12.73
- NBB $16.66
- Technical
- Relative Strength Index (RSI)
- EBS 65.40
- NBB 59.86
- Support Level
- EBS $8.58
- NBB $15.95
- Resistance Level
- EBS $9.34
- NBB $16.41
- Average True Range (ATR)
- EBS 0.38
- NBB 0.14
- MACD
- EBS 0.10
- NBB 0.01
- Stochastic Oscillator
- EBS 85.94
- NBB 71.74
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests a majority of its assets in a diversified portfolio of taxable municipal securities.